BCL2L2 and neoplasm: Our scRNA-seq and ST analyses revealed that BCL2 (BCL-2) and BCL2L2 (BCL-w) are expressed at low levels in tumor cells and have low tumor specificity (Figs. 3B, E, H, K, N and 4A).